Company Filing History:
Years Active: 2008
Title: Mohan Ramachandran Wani: Innovator in Osteoporosis Treatment
Introduction
Mohan Ramachandran Wani is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of medical science, particularly in the treatment of osteoporosis. His innovative approach has led to the development of a unique method and composition that addresses this prevalent condition.
Latest Patents
Mohan Ramachandran Wani holds a patent for a method and composition for treating osteoporosis. This invention relates to a novel class of acidic amino acid/dicarboxylic acid derivatives, specifically sulfonic acid/sulfate derivatives of naturally occurring amino acids and their amides. The patent outlines the use of these derivatives as inhibitors of osteoclastogenesis. The general formula for these compounds is ZOC—(CRR)—COOH, where m can be 2, 3, or 4. The variable Z can be OH or NH, and one R in the compound is selected from a group consisting of SOH, OSOH, CH—SOH, CH—OSOH, and NHSOH, while the remaining Rs can be H or NH. This innovative method provides a promising avenue for the inhibition of osteoclastogenesis.
Career Highlights
Mohan Ramachandran Wani is associated with the Council of Scientific & Industrial Research, where he has been instrumental in advancing research in his field. His work has not only contributed to scientific knowledge but also has practical implications for treating osteoporosis.
Collaborations
Mohan has collaborated with esteemed colleagues such as Kanury Venkata Subba Rao and Venkatasamy Manivel. These collaborations have further enriched his research and innovation efforts.
Conclusion
Mohan Ramachandran Wani's contributions to the treatment of osteoporosis through his patented methods highlight his role as a significant innovator in the medical field. His work continues to inspire advancements in healthcare solutions.